Table 3. PMR's knowledge on dosing SP and AQ medicines for under fives.
| Adequacy on dosages for anti-malarial medicines recommended | Kisii site | Kwale site | ||||||
| I n (%) | C n (%) | P | OR (95% CI) | I n (%) | C n (%) | P | OR (95% CI) | |
| Dosing of AQ medicines available* | ||||||||
| Recommended AQ adequately | 46/58 (79.3%) | 7/42 (16.7%) | <0.001 | 18.6 (6.6, 52.2) | 21/43 (48.8%) | 0/58 (0%) | 1.000 | na |
| Recommended AQ in over dose | 3/58 (5.2%) | 17/42 (40.5%) | <0.001 | 0.08 (0.2, 0.3) | 12/43 (27.9%) | 18/58 (31.0%) | 0.734 | 0.9 (0.3, 2.4) |
| Recommended AQ in under dose | 8/58 (13.8%) | 17/42 (40.5%) | 0.002 | 0.2 (0.08, 0.6) | 10/43 (23.3%) | 34/58 (58.6%) | <0.001 | 0.2 (0.1, 0.5) |
| Recommended AQ for one day | 8/58 (13.8%) | 19/42 (45.2%) | <0.001 | 0.2 (0.07, 0.5) | 3/43 (6.9%) | 34/58 (60.3%) | <0.001 | 0.03 (0.004, 0.3) |
| Dosing of SP medicines available | ||||||||
| Recommended SP adequately | 1/5 (20.0%) | 8/20 (40.0%) | 0.405 | 0.4 (0.04, 3.9) | 11/23 (47.8%) | 14/32 (43.7%) | 0.765 | 1.2 (0.4, 3.4) |
| Recommended SP in high dose | 4/5 (80.0%) | 12/20 (60.0%) | 0.621 | 2.7 (0.3, 28.4) | 6/23 (26.1%) | 10/32 (31.2%) | 0.678 | 0.8 (0.2, 2.6) |
| Recommended SP in low dose | 0/5 | 0/20 | NA | NA | 6/23 (26.1%) | 8/32 (25.0%) | 0.927 | 1.1 (0.3, 3.6) |
| Recommended SP for three days | 4/5 (80.0%) | 6/20 (30.0%) | 0.121 | 9.3 (0.9, 101.2) | 11/23 (47.8%) | 3/32 (9.4%) | 0.002 | 8.9 (2.1, 37.5) |
Throughout this paper the following labels apply to all the tables. I = intervention area (Kiamokama in Kisii and Kinango and Matuga in Kwale); C = control area (Suneka of Kisii and Msambweni and Samburu of Kwale) = P value for comparison of intervention and control in each site; OR = odds ratio of the comparison between control and intervention in each site.
†Use of NA -represents cases where that measure was not applicable or could not be derived.